Sun Pharma Advanced Research Company today reported a standalone net loss of Rs 18.91 crore for the quarter ended December 31, 2014.
The company had posted a net profit if Rs 30.97 crore for the corresponding period of the previous fiscal, Sun Pharma Advanced Research Company (SPARC) said in a filing to BSE.
Standalone total income of the company stood at Rs 32.21 crore for the quarter under consideration. It was Rs 65.07 crore for the same period year ago, it added.
Shares of Sun Pharma Advanced Research Company today closed at Rs 328.40 on BSE, down 5.94 per cent from previous close.